Researchers find that SARS-CoV-2 spike protein persists in the skull-meninges-brain axis, driving neuroinflammation, ...

Researchers from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have identified a mechanism that may explain the ...

A new study reveals that the SARS-CoV-2 spike protein remains in brain-protective tissues and skull bone marrow for years after infection, potentially driving long COVID's neurological symptoms.

In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Researchers have identified that the SARS-CoV-2 spike protein accumulates in the brain's protective layers, potentially ...

In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can ...

Explore groundbreaking research linking SARS-CoV-2 spike protein accumulation to long-lasting brain effects in long COVID.

Robert Redfield says he's "proud" of work on President Trump's initiative but believes COVID vaccines should be "critically ...

Engineered proteins are critical industrial and medical applications, ranging from vaccine development to making crops or food proteins more resilient. Scientists can engineer proteins to improve upon ...